This Christmas miracle improves cancer survival by up to 40 percent

Kissing under the mistletoe is a much-loved—and much-sung-about—holiday tradition.

But this festive, white-berried evergreen isn’t just for kissing at Christmas time…

In fact, in an eye-opening German study, people with colon, stomach, rectum, breast, or lung cancer who received mistletoe treatments improved their survival by up to 40 percent!

I’ll tell you all about that remarkable study in just a moment.

But first, let’s back up to discuss the history of this storied plant…

Long history of use as a natural remedy

More than 2,000 years ago, the ancient Celts and Druids in Britain believed mistletoe (Viscum album) had magical powers to heal—as it grows on trees, without roots to the ground, and stays green in the middle of winter.

As time went on, Europeans began using this “all-heal” plant, as they called it, to treat lots of common health conditions, such as headaches and arthritis.

Then, in 1916, Rudolf Steiner, Ph.D., began researching mistletoe as a cancer treatment. At the time, most scientists still considered mistletoe just a folk remedy. However, Dr. Steiner believed it had unique and powerful biologic properties…

More than a century ago, he recognized that we have properties in our bodies that influence cell growth—either promoting it or controlling it. And that cancer can occur if those forces become imbalanced. He theorized that a liquid extract of mistletoe could help reestablish that balance and potentially fight cancerous tumors.

While that description may sound a little dated, current research seems to support Dr. Steiner’s conceptual work. In fact, more modern studies show that mistletoe extract appears to:

  • Block cancer growth and even kill cancer cells directly.
  • Support the body’s immune system.
  • Improve the well-being and survival rates of people with melanoma and cancer of the cervix, ovary, breast, stomach, colon, and lung.

The research on mistletoe keeps getting stronger

Iscador is the most used—and widely studied—variety of mistletoe extract. It comes from a European species of mistletoe that differs slightly from the American species. And there are nearly 200 studies on Iscador in humans and animals.

In fact, as I mentioned earlier, in 2001, German researchers conducted one of the best-known trials on Iscador. It involved more than 10,000 people with cancer of the colon, stomach, rectum, breast, or lung. And results showed that the people who received Iscador injections had a staggering 40 percent longer survival time than people who didn’t have the injections.

With these kinds of results, no wonder mistletoe extract is one of the most widely prescribed cancer treatments in all of Europe!

Yet, astoundingly, the U.S. Food and Drug Administration (FDA) still refuses to approve it as a treatment for cancer…or as a treatment for any medical condition.

However, there are some practitioners willing to prescribe mistletoe extract to patients in the U.S. and Canada. So, if you or someone you know might be a candidate, consult with your physician—then weigh your options. It may mean doing some research to find a practitioner willing to help (or taking a trip to Europe).

You can learn much more about the potential of mistletoe as a cancer treatment in my Authentic Anti-Cancer Protocol. It’s a comprehensive, online, learning tool that discusses no-nonsense, all-natural secrets for lifetime prevention and survival. To learn more, or to enroll today, click here.

And…I wish you and your family much joy, health, and happiness this Christmas season. Perhaps you’ll even find yourself under a sprig of mistletoe!


CLOSE
CLOSE